Research advances in induced pluripotent stem cells in Alzheimer's disease

VernacularTitle:诱导性多能干细胞在阿尔茨海默病治疗研究中的应用进展
Author: Shiqi ZHU ; Feng LI
From: Chinese Journal of Tissue Engineering Research 2017;21(21):3426-3431
CountryChina
Language:Chinese
Abstract: BACKGROUND:Induced pluripotent stem cell (iPSC) technique is a newborn technology reprogramming human somatic cells into pluripotent stem cells, which can be used in disease modeling, drug screening and cell therapy. OBJECTIVE: To analyze the feasibility and advances of iPSC application in Alzheimer's disease, and conclude the insufficient and future of this technology. METHODS:CNKI and PubMed were searched for relevant articles concerning Alzheimer's disease and iPSCs, and the retrieval results were screened by relativity and repeatability. Finally, 30 articles were included in result analysis. RESULTS AND CONCLUSION: This review concludes the superiority of iPSC technology in the treatment of neurodegenerative diseases and in vivo harvest of nerve cells. The use of inducible pluripotent stem cells differentiated from patient's own cells is more practicable, but there are still many problems to solve at this stage, such as high-efficient and stable directional differentiation, safety of induced pluripotent stem cells, the most appropriate donor cells, and ethical disputes.